B. Braun Executive and Leadership Team

Connie BraunMD, the Chief Executive Officer at B. Braun, directs the overarching strategic vision for the multinational medical device and pharmaceutical portfolio. Overseeing global operations, the Chief Executive Officer ensures alignment between manufacturing excellence and the evolving needs of hospital pharmacy solutions. This leadership role involves managing complex international market expansion across 60 countries while maintaining the highest standards of clinical safety. By optimizing the integration of infusion therapy and surgical instrument divisions, Connie BraunMD directly impacts the long-term growth trajectory of the organization. The Chief Executive Officer collaborates with the board to refine corporate governance and drive sustainable innovation in wound care and dialysis technologies. Ultimately, the Chief Executive Officer secures the competitive position of the firm within the global healthcare landscape, ensuring that every strategic initiative supports the core mission of improving patient health through advanced medical engineering and reliable pharmaceutical supply chains.

Leo Arce, the Chief Financial Officer at B. Braun, manages the global fiscal health and capital allocation strategies for the medical device enterprise. Overseeing financial reporting and risk management, the Chief Financial Officer ensures that investment in research and development remains consistent with long-term profitability goals. This leadership role involves analyzing market trends in infusion therapy and surgical instruments to optimize resource distribution across international subsidiaries. By implementing rigorous cost-control measures, Leo Arce directly impacts the operational efficiency of the company. The Chief Financial Officer coordinates with regional finance teams to maintain transparency and regulatory compliance in diverse economic environments. Ultimately, the Chief Financial Officer strengthens the balance sheet, providing the necessary capital stability to support the ongoing development of life-saving medical products and pharmaceutical solutions that define the market presence of the organization.

Cristian Vacarezza, the Principal Chief Financial Officer at B. Braun, leads the strategic financial planning and corporate treasury functions for the organization. Overseeing complex financial modeling, the Principal Chief Financial Officer ensures that capital investments align with the long-term manufacturing goals for surgical instruments and wound care products. This leadership role involves evaluating the financial viability of new market entries and assessing the impact of currency fluctuations on global revenue streams. By optimizing tax structures and liquidity management, Cristian Vacarezza directly impacts the financial resilience of the company. The Principal Chief Financial Officer works closely with the executive team to provide actionable insights that guide major business decisions. Ultimately, the Principal Chief Financial Officer maintains the fiscal integrity of the firm, ensuring that the financial foundation remains strong enough to support continuous innovation in medical technology and pharmaceutical services.

Flavio Santos, the Chief Financial Officer, At El Salvador Caribe & Paraguay (Central America) at B. Braun, directs the financial operations and regional growth strategies across the Central American and Caribbean markets. Overseeing local fiscal compliance and budget management, the Chief Financial Officer, At El Salvador Caribe & Paraguay (Central America) ensures that regional sales of infusion therapy and dialysis products meet corporate profitability targets. This leadership role involves navigating the unique economic landscapes of these territories to maximize market penetration and operational efficiency. By managing local financial risks and optimizing regional supply chain costs, Flavio Santos directly impacts the profitability of the organization in these key emerging markets. The Chief Financial Officer, At El Salvador Caribe & Paraguay (Central America) coordinates with global headquarters to ensure alignment with international standards. Ultimately, the Chief Financial Officer, At El Salvador Caribe & Paraguay (Central America) secures the financial health of regional operations, facilitating the expansion of medical services.

Yazmin Ruiz, the Chief Financial Officer (Mexico) at B. Braun, manages the financial strategy and operational accounting for the Mexican market. Overseeing local revenue cycles and cost management, the Chief Financial Officer (Mexico) ensures that the distribution of surgical instruments and hospital pharmacy solutions remains profitable within the region. This leadership role involves analyzing local market demand and adjusting financial forecasts to support the growth of the medical device portfolio. By implementing efficient financial controls, Yazmin Ruiz directly impacts the regional bottom line and supports the broader corporate objective of market leadership. The Chief Financial Officer (Mexico) collaborates with regional management to ensure that all financial activities adhere to both local regulations and global corporate policies. Ultimately, the Chief Financial Officer (Mexico) provides the financial stability required to sustain the company's strong presence in the Mexican healthcare sector, ensuring consistent delivery of high-quality medical products.

Thomas Whalen, the Interim Chief Financial Officer (North America) at B. Braun, oversees the financial planning and analysis for the North American division. Managing the fiscal health of the region, the Interim Chief Financial Officer (North America) ensures that resources are effectively allocated to support the manufacturing and marketing of medical devices. This leadership role involves monitoring regional performance metrics and identifying opportunities for cost optimization in the supply chain. By providing accurate financial reporting, Thomas Whalen directly impacts the strategic decision-making process for the North American market. The Interim Chief Financial Officer (North America) works with regional leadership to maintain financial discipline while pursuing growth in infusion therapy and wound care sectors. Ultimately, the Interim Chief Financial Officer (North America) ensures that the regional financial operations remain robust and aligned with the global mission, supporting the continued delivery of essential medical solutions to healthcare providers across the continent.

Edwin Omar, the Chief Financial Officer & Bbraun Medical Peru S A Board Member at B. Braun, directs the financial strategy and governance for the Peruvian operations. Overseeing the financial health of the local entity, the Chief Financial Officer & Bbraun Medical Peru S A Board Member ensures that the company maintains a competitive edge in the delivery of medical products. This leadership role involves participating in board-level decisions that shape the long-term direction of the business in Peru. By managing local financial risks and optimizing operational budgets, Edwin Omar directly impacts the success of the organization in the South American market. The Chief Financial Officer & Bbraun Medical Peru S A Board Member coordinates with regional and global teams to ensure financial transparency and compliance. Ultimately, the Chief Financial Officer & Bbraun Medical Peru S A Board Member secures the financial foundation necessary to provide high-quality medical solutions to the Peruvian healthcare system.

Scott Farrell, the Group Chief Financial Officer at B. Braun, manages the consolidated financial performance and global investment strategy for the entire multinational organization. Overseeing the group-wide financial reporting and capital structure, the Group Chief Financial Officer ensures that the company maintains the financial flexibility to invest in cutting-edge medical research and manufacturing technology. This leadership role involves coordinating with regional financial heads to ensure consistency in financial practices across all 60 countries. By driving group-level efficiency and managing global financial risks, Scott Farrell directly impacts the overall profitability and market valuation of the firm. The Group Chief Financial Officer works closely with the executive board to align financial goals with the company's mission of advancing healthcare. Ultimately, the Group Chief Financial Officer provides the strategic financial oversight necessary to sustain the company's position as a global leader in medical devices and pharmaceutical solutions.

Punrada Lertkomonsuk, the Chief Financial Officer, B Braun Ltd (Thailand) at B. Braun, leads the financial operations and strategic planning for the Thai market. Overseeing local accounting, tax compliance, and financial planning, the Chief Financial Officer, B Braun Ltd (Thailand) ensures that the regional business unit operates with maximum efficiency. This leadership role involves analyzing local market trends to support the distribution of medical products and pharmaceutical solutions. By managing regional budgets and optimizing financial processes, Punrada Lertkomonsuk directly impacts the profitability of the Thai operations. The Chief Financial Officer, B Braun Ltd (Thailand) collaborates with regional management to ensure that financial strategies support the broader corporate objectives of growth and innovation. Ultimately, the Chief Financial Officer, B Braun Ltd (Thailand) maintains the financial health of the local entity, ensuring that the company can continue to provide essential medical services to the healthcare sector in Thailand.

Prit Patel, the Chief Information Officer at B. Braun, architects the digital infrastructure and data security frameworks supporting global medical manufacturing operations. Overseeing the integration of advanced information systems, the Chief Information Officer ensures that hospital pharmacy solutions and dialysis data remain secure and accessible. This leadership role involves driving digital transformation initiatives that streamline supply chain logistics and enhance manufacturing precision. By leveraging data analytics to monitor product performance, Prit Patel directly impacts the quality and reliability of medical devices delivered to healthcare providers. The Chief Information Officer collaborates with cross-functional teams to implement robust cybersecurity protocols across all international branches. Ultimately, the Chief Information Officer enables seamless connectivity between internal production units and external clinical partners, fostering a technology-driven environment that accelerates the delivery of innovative healthcare products to patients worldwide.